Date, May 18th, 2021. Today, Deep Longevity (wholly owned by Regent Pacific Group Limited Hong Kong Stock Code: 00575) a leading provider of deep biomarkers of aging and longevity, LifeHub, and LifeClinic announced a collaboration to deploy an extensive range of AI-powered aging clocks to explore the effectiveness of longevity interventions including lifestyle choices and drug regimens.
Based in Hong Kong, LifeHub and LifeClinic are possibly the largest Functional Medicine-based Medical Wellness and Medical Clinic facilities in the region. They take a science-based approach to Health Optimization and Longevity by addressing their clients' physiological imbalances that could stem from nutritional deficiencies or other factors like hormonal imbalances or the effects of environmental pollutants.
As part of the partnership, LifeHub and LifeClinic medical professionals are being engaged in advanced research with Deep Longevity and trained in deep aging clocks to provide their clients with biological age reports to customize their clients' wellness journeys.
Deep Longevity aging clocks are supported by a number of academic publications that are summarized in a recent review titled "BioHorology and biomarkers of aging: Current state-of-the-art, challenges, and opportunities".
Biological Aging clocks are a new holistic biomarker of health and wellbeing that reflect the biological age of the person, and not their passport age. These markers are usually much more predictive of mortality and can be used for early disease diagnosis, prevention, clinical trial management and in insurance applications. Deep Longevity is the original inventor of deep aging clocks - biomarkers of aging using deep learning and has granted patents on the technology.
"I am delighted that we will be able to use Deep Longevity's most advanced aging clocks to assess and improve LifeHub and LifeClinic's various youth extension products and services", said Dr Jonathan Seah, Chairman of LifeHub and LifeClinic.
"The traditional approach to preventative medicine is focused on preventing disease by diagnosing the symptoms early or reducing the risks of disease. AI-guided longevity medicine goes much further than that by focusing on tracking the person's rates of aging at many levels, on the identification of longevity bottlenecks, and on utilizing the latest advances in science and technology to slow down or potentially even reverse biological and psychological aging. We are very happy to have both LifeHub and LifeClinic join the rapidly growing network of our research and clinical partners focused on providing customers with extra years of productive and happy life", said Dr Alex Zhavoronkov, Chief Longevity Officer of Deep Longevity Inc.
About Regent Pacific (SEHK:0575.HK)
Regent Pacific is a diversified investment group based in Hong Kong currently holding various corporate and strategic investments focusing on the healthcare, wellness and life sciences sectors. The Group has a strong track record of investments and has returned approximately US$298 million to shareholders in the 21 years of financial reporting since its initial public offering.
About Deep Longevity
Deep Longevity is wholly owned by Regent Pacific (SEHK:0575.HK), whose shares are listed on the Hong Kong Stock Exchange. Deep Longevity is developing explainable artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. It is also developing systems for the emerging field of longevity medicine enabling physicians to make better decisions on the interventions that may slow down, or reverse the aging processes. Deep Longevity developed Longevity as a Service (LaaS)© solution to integrate multiple deep biomarkers of aging dubbed "deep aging clocks" to provide a universal multifactorial measure of human biological age. Originally incubated by Insilico Medicine, Deep Longevity started its independent journey in 2020 after securing a round of funding from the most credible venture capitalists specializing in biotechnology, longevity, and artificial intelligence. ETP Ventures, Human Longevity and Performance Impact Venture Fund, BOLD Capital Partners, Longevity Vision Fund, LongeVC, co-founder of Oculus, Michael Antonov, and other expert AI and biotechnology investors supported the company. Deep Longevity established a research partnership with one of the most prominent longevity organizations, Human Longevity, Inc. to provide a range of aging clocks to the network of advanced physicians and researchers.
About LifeHub & LifeClinic
LifeClinic is a leading Medical Anti-Aging clinic in Hong Kong that uses Functional Medicine and Swiss Biological Medicine to help its clients to work and play better and to reduce illness by optimizing health and extending biological youth. LifeClinic's team of medical doctors and other healthcare practitioners create customized programs for diet and micronutrient optimization, the reduction of environmental pollutants and other toxins, hormone balancing, and other innovative therapies, to help with healthy aging issues like chronic fatigue or problems with sleep, memory, weight, digestion, and sex, and also chronic diseases like diabetes, heart diseases and cancer. LifeClinic also provides aesthetic medicine services including laser and other minimally-invasive treatments. ( https://lifeclinic.com.hk )
LifeHub is the first Lifestyle Medical Wellness company whose vision is to empower everyone to work and play better and to reduce illness by optimizing health and extending biological youth via Functional Medicine health optimization services and products in convenient locations. In addition to a range of scientifically-designed tests, cosmeceuticals and other consumable supplements, LifeHub also provides IV and IM treatments via its medical partners, which enable the optimal absorption of many essential nutrients. LifeHub in Hong Kong is located in Central, at 33 Wellington Street. ( https://thelifehub.com )